Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VRAX

Virax Biolabs (VRAX)

Virax Biolabs Group Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VRAX
DateTimeSourceHeadlineSymbolCompany
03/18/20258:10AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
03/18/20257:30AMPR Newswire (US)Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection SyndromesNASDAQ:VRAXVirax Biolabs Group Ltd
03/13/20258:13AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
03/13/20257:30AMPR Newswire (US)Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation MeetingNASDAQ:VRAXVirax Biolabs Group Ltd
03/05/20257:44AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
03/05/20257:30AMPR Newswire (US)Virax Biolabs to Present at 19th World Immune Regulation MeetingNASDAQ:VRAXVirax Biolabs Group Ltd
02/25/20257:25AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
02/25/20257:00AMPR Newswire (US)Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine EfficacyNASDAQ:VRAXVirax Biolabs Group Ltd
01/30/20254:45PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VRAXVirax Biolabs Group Ltd
12/23/20248:50AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
12/17/20248:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
12/17/20247:30AMPR Newswire (US)Virax Biolabs' CEO James Foster Issues Letter to ShareholdersNASDAQ:VRAXVirax Biolabs Group Ltd
12/10/20247:36AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
12/10/20247:30AMPR Newswire (US)Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and SwitzerlandNASDAQ:VRAXVirax Biolabs Group Ltd
11/20/20244:03PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
10/31/20248:09AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
10/23/20248:50AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
10/23/20247:30AMPR Newswire (US)Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and IrelandNASDAQ:VRAXVirax Biolabs Group Ltd
09/30/20249:14AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
09/30/20249:13AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VRAXVirax Biolabs Group Ltd
09/16/20248:30AMPR Newswire (US)Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.NASDAQ:VRAXVirax Biolabs Group Ltd
09/09/20248:00AMPR Newswire (US)Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment ConferenceNASDAQ:VRAXVirax Biolabs Group Ltd
08/29/20249:03AMPR Newswire (US)Virax Biolabs to Participate at 7th European Congress of ImmunologyNASDAQ:VRAXVirax Biolabs Group Ltd
08/28/20247:30AMPR Newswire (US)Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle EastNASDAQ:VRAXVirax Biolabs Group Ltd
08/23/20244:09PMPR Newswire (US)Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary SharesNASDAQ:VRAXVirax Biolabs Group Ltd
08/23/20248:55AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
08/23/20248:54AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VRAXVirax Biolabs Group Ltd
08/21/20249:30PMPR Newswire (US)Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary SharesNASDAQ:VRAXVirax Biolabs Group Ltd
08/20/20244:24PMEdgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:VRAXVirax Biolabs Group Ltd
08/01/20247:48AMEdgar (US Regulatory)Form NT 20-F - Notification of inability to timely file Form 20-FNASDAQ:VRAXVirax Biolabs Group Ltd
 Showing the most relevant articles for your search:NASDAQ:VRAX